GENE ONLINE|News &
Opinion
Blog

Gilead Sciences
COVID-19 Remdesivir
Fight against COVID-19 Strengthens as Gilead Launches Phase III Trial for Remdesivir
2020-02-28
COVID-19 Vaccine
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
COVID-19
Update On 2019 Novel Coronavirus (2019-nCov): The Latest Progress In Vaccine Development And Treatment
2020-01-30
Manufacturing
The 38th Annual J.P. Morgan Healthcare Conference – What to Expect?
2020-01-13
Weekly in Asia｜Dec-3
2020-01-02
HIV
Weekly in Asia 2019｜AUG-1
2019-08-17
Asia-Pacific
Weekly in Asia 20190602-0608
2019-06-11
IPO Acute Lymphoblastic Leukemia
Tracking “OFF THE SHELF” CAR-T Cell therapy & an IPO worth $100M
2018-10-15
1 … 3 4 5
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top